Browsing Tag
COPD treatment
5 posts
Adherium (ASX: ADR) turns pilot into performance with RPM success across Allergy Partners
Adherium’s RPM expansion through Allergy Partners hits a key milestone in the U.S., but will 4,000 patients be enough to lift its ASX share price from record lows?
Trump announces second MFN pricing deal as AstraZeneca slashes drug costs for millions
AstraZeneca to offer most-favored-nation drug prices to U.S. Medicaid and invest $50B in American pharma manufacturing. Find out what it means for patients.
Senores Pharmaceuticals expands US footprint with Roflumilast ANDA acquisition
Senores Pharmaceuticals Limited has taken a significant step in its US expansion strategy by acquiring an Abbreviated New…
EMA approves Dupixent as first biologic for COPD with elevated eosinophils
The European Medicines Agency (EMA) has granted approval to Dupixent (dupilumab) as a novel add-on maintenance treatment for…
Understanding Chronic Obstructive Pulmonary Disease (COPD): A comprehensive guide
Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that encompasses emphysema and chronic bronchitis, often…